Aluminum Silicate Patents (Class 424/684)
  • Patent number: 10688322
    Abstract: The present invention relates to the use of a polysaccharide selected from the group of non-modified polysaccharides, chemically modified polysaccharides and physically modified polysaccharides, in antiperspirant cosmetic agents, the use of these polysaccharides resulting in an excellent reduction and/or prevention of textile discoloration and/or textile stains.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: June 23, 2020
    Assignee: Henkel AG & Co. KGaA
    Inventors: Bernhard Banowski, Marcus Claas, Imme Breuer
  • Patent number: 10226513
    Abstract: The present invention relates generally to compositions and methods of using compositions comprised of undenatured cartilage in the form of an isolated native Type II collagen that may be combined in a synergistic blend with one or more edible metals with acceptable chemical counter-ions or other health promoting ingredients to be orally consumed as a method for preventing and improving symptoms of musculoskeletal distress degeneration, including symptoms selected from temporary loss of range of motion, temporary inflammation, temporary muscle soreness, and combinations thereof. The synergistic compositions of the present invention also protect, promote and improve recovery from and prevention of cartilage and ligament wear, thinning and damage to bone, and repetitive motion injuries and stress resulting from intense periods of activity or workout routines that contribute to such musculoskeletal distress degeneration symptoms.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: March 12, 2019
    Inventor: Mark Terrell Smith
  • Patent number: 10206948
    Abstract: Methods are provided to make clinoptilolite into a water-soluble hydrolyzed form suitable for various administration routes, including oral administration. Absorption of water-soluble hydrolyzed clinoptilolite fragments can aid in detoxification by binding heavy metals and environmental toxins, can reduce reactive oxygen species and inflammation related to heavy metals and other/environmental toxins, resulting in an increase in energy, and/or in an increase in one or more of focus, concentration, and memory. Water-soluble hydrolyzed clinoptilolite fragments can be combined with one or more dietary supplements, including various vitamins and sleep aids.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: February 19, 2019
    Inventor: Nikolaos Tsirikos-Karapanos
  • Patent number: 9415064
    Abstract: Prevention or treatment of painful polyneuropathies caused by toxic agents, i.e. to the prevention, reduction or elimination of the symptoms associated with such polyneuropathies, such as neuropathic pain are disclosed. An aluminosilicate for use in such prevention or treatment, preferably a natural or synthetic zeolite, such as clinoptilolite, is provided. The toxic agent is, in particular, a chemotherapeutic cytotoxic agent.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: August 16, 2016
    Inventor: Jakob Hraschan
  • Publication number: 20150118314
    Abstract: A topical composition comprises a clay material with a negative surface charge; magnesium ions and calcium ions; water and/or a non-aqueous solvent; and a substantially non-cationic carrier. The mean particle size of the clay material is at least 5 nm, and the total molar amount of magnesium ions is higher than the total molar amount of calcium ions. The composition is suitable for the prophylaxis and treatment of skin diseases, skin conditions, or mucosal diseases.
    Type: Application
    Filed: January 2, 2015
    Publication date: April 30, 2015
    Inventors: Attila Feleki, Theodorus A. C. Migo
  • Publication number: 20150110886
    Abstract: The present invention generally relates to methods of treating hypertension (HTN) in patients in need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). The invention also relates to methods of treating hyperkalemia in a patient in need thereof, wherein the patient suffers from CKD, T2DM or HTN and are optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The invention also relates to methods of treating kidney disease in a patient in need thereof, wherein the patient is optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The methods can comprise administering an effective amount of a potassium-binding agent to the patient to lower the patient's blood pressure and/or increase or stabilize the patient's kidney function.
    Type: Application
    Filed: December 23, 2014
    Publication date: April 23, 2015
    Inventors: Gerrit Klaerner, Lance Berman
  • Patent number: 9005673
    Abstract: A preservative and additive for food and feed. One aspect of the invention concerns various acidified clays and minerals as food or feed additive to kill, or inhibit the growth of, harmful microorganisms and to inactivate mycotoxins, such as aflatoxins, present as contaminants in human foods and animal feeds. Another aspect of the present invention relates to a clay of hydrated sodium calcium aluminosilicate with relatively uniform particle size distribution.
    Type: Grant
    Filed: July 17, 2006
    Date of Patent: April 14, 2015
    Inventors: Robert H. Carpenter, Maurice Clarence Kemp, K. Scott McKenzie
  • Patent number: 8956664
    Abstract: The present disclosure relates generally to the field of mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing mucositis are provided by administering a clay to the subject in need.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: February 17, 2015
    Assignee: Salient Pharmaceuticals Incorporated
    Inventor: Richard M. Scruggs
  • Publication number: 20140377362
    Abstract: Compositions that include a clay such as kaolin dispersed in a liquid such as water may be useful for promoting the clotting of blood. The compositions may be in a liquid, gel, paste, foam, or another form. Uses may include treating a traumatic injury such as in injury caused by a bullet, an explosive, a blade etc., or an injury caused during a medical procedure such as surgery.
    Type: Application
    Filed: September 5, 2014
    Publication date: December 25, 2014
    Inventors: Mohan Prasad Pahari, Giacomo Basadonna, Denny Lo
  • Publication number: 20140308337
    Abstract: Hemostatic compositions comprising a wet layered clay (e.g., wet kaolin) and, optionally, a zeolite, as well as devices and methods of use to promote blood clotting, are provided.
    Type: Application
    Filed: March 5, 2014
    Publication date: October 16, 2014
    Applicant: The Regents of the University of California
    Inventors: Sarah Baker, April Sawvel, Galen D. Stucky
  • Patent number: 8840914
    Abstract: Methods of fabricating implantable medical devices, preferably with PEEK, having antimicrobial properties, are disclosed. The antimicrobial effect is produced by incorporating ceramic particles containing antimicrobial metal cations into molten PEEK resin, which is subsequently allowed to cool and set in its final shape achieved by injection molding, cutting and machining or other techniques.
    Type: Grant
    Filed: October 17, 2012
    Date of Patent: September 23, 2014
    Assignee: DiFusion Technologies, Inc.
    Inventors: Joseph J. Crudden, Jami Hafiz, James E. Deaton, John R. Pepper, Derrick Johns
  • Patent number: 8821912
    Abstract: Methods of fabricating implantable medical devices, preferably with PEEK, having antimicrobial properties, are disclosed. The antimicrobial effect is produced by incorporating ceramic particles containing antimicrobial metal cations into molten PEEK resin, which is subsequently allowed to cool and set in its final shape achieved by injection molding, cutting and machining or other techniques.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: September 2, 2014
    Assignee: DiFusion Technologies, Inc.
    Inventors: Joseph J. Crudden, Jami Hafiz, James E. Deaton, John R. Pepper, Derrick Johns
  • Patent number: 8795718
    Abstract: The present invention utilizes a nano-coating of an oxide such as silica, a silicate or another effective oxide on a surface to accelerate blood clotting in mammalian animals. The hemostatic layer has a thickness that is effective for the hemostasis, yet can be made thin enough to result in a resorbable film which can either be applied to a biocompatible or resorbable device that can be used in surgical applications as well as in topical applications such as trauma.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: August 5, 2014
    Assignee: Honeywell International, Inc.
    Inventors: Robert L. Bedard, Steven A. Wilcher
  • Patent number: 8790668
    Abstract: The present invention relates to a personal care composition that contains a rinse-off composition which deposits at least 0.5 ?g/cm2 of shiny particles on the skin. Preferably, the shiny particles are hydrophobically modified interference pigments. The inventors have found that hydrophobically modifying the particles significantly improves the deposition of the particles on skin from rinsable compositions.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: July 29, 2014
    Assignee: The Procter & Gamble Company
    Inventors: Mannie Lee Clapp, Cynthia Ann Garza, Qing Stella, Paul Robert Tanner, Rebecca Ann Taylor
  • Patent number: 8769868
    Abstract: The invention relates to a microbial biomass composition produced from a heterotrophic fermentation whose fatty acid profile exhibits: an eicosapentaenoic acid (EPA) to arachidonic acid (ARA) ratio of about 11:1 or more; an EPA to total co-concentrating fatty acid ratio of about 8:1 or more, extract compositions, and methods of producing such compositions.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: July 8, 2014
    Assignee: Photonz Corporation Limited
    Inventors: Hywel David Griffiths, Karl Thomas Geiringer, Mark Humphrey Dines
  • Patent number: 8758775
    Abstract: The invention is for a method of potentiating clinoptilolite, the method including the steps of: providing fresh or spent clinoptilolite; exposing the clinoptilolite to a saline solution having a sodium ion content of about 10% to liberate impurities from the clinoptilolite; and drying the washed clinoptilolite fraction to render a potentiated clinoptilolite fraction. Preferably, the clinoptilolite is exposed to the saline solution for a period of about 48 hours. The washed clinoptilolite may be dried by filtered, heated air. This allows an optimal cation exchange capacity of the clinoptilolite to be reached. The clinoptilolite has uses as a medicament for a variety of aliments.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: June 24, 2014
    Inventor: Kevin Gast
  • Patent number: 8722103
    Abstract: There is described zeolites containing releasably adsorbed nitric oxide, methods of preparing the zeolites, methods of releasing the nitric oxide into a solution or into air and uses of the zeolites in therapy.
    Type: Grant
    Filed: July 5, 2004
    Date of Patent: May 13, 2014
    Assignee: University Court of the University of St. Andrews
    Inventors: Russell Edward Morris, Paul Stewart Wheatley, Anthony Robert Butler
  • Publication number: 20140099373
    Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 10, 2014
    Applicant: Oil-Dri Corporation of America
    Inventors: Jonathan Broomhead, Fang Chi, Ron Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
  • Publication number: 20140072658
    Abstract: The present invention relates to a new class of anitoxidant agent comprising a pharmaceutically acceptable silicate, resveratrol, grape seeds extract, green tea extract and tomato powder. In particular this composition comprises between 32 to 60 percent by weight of a pharmaceutically acceptable silicate, between 6 to 22 percent by weight of resveratrol, between 16 to 20 percent by weight of grape seeds extract, between 8 to 10 percent by weight of green tea extract, and between 10 to 16 percent by weight of tomato powder.
    Type: Application
    Filed: May 15, 2012
    Publication date: March 13, 2014
    Inventor: Slavko Ivkovic
  • Publication number: 20140056837
    Abstract: Nanocomposite compositions forming mixed clathrates and methods for using such compositions for entrapping guest moieties such as malodors, molds and cells are disclosed.
    Type: Application
    Filed: March 4, 2013
    Publication date: February 27, 2014
    Inventors: Allan D. PRONOVOST, Michael E. HICKEY
  • Publication number: 20140057000
    Abstract: The invention relates to the prevention or treatment of painful polyneuropathies caused by toxic agents, i.e. to the prevention, reduction or elimination of the symptoms associated with such polyneuropathies, such as neuropathic pain. The invention provides an aluminosilicate for use in such prevention or treatment, preferably a natural or synthetic zeolite, such as clinoptilolite. The toxic agent is, in particular, a chemotherapeutic cytotoxic agent.
    Type: Application
    Filed: December 4, 2012
    Publication date: February 27, 2014
    Inventor: Jakob Hraschan
  • Publication number: 20140044804
    Abstract: The present invention provides methods and compositions for the treatment of ion imbalances using core-shell composites and compositions comprising such core-shell composites. In particular, the invention provides core-shell particles and compositions comprising potassium binding polymers, and core-shell particles and compositions comprising sodium binding polymers, and in each case, pharmaceutical compositions thereof. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and/or prophylactic benefits are also disclosed. The compositions and methods of the invention offer improved approaches for treatment of hyperkalemia and other indications related to potassium ion homeostasis, and for treatment of hypertension and other indicates related to sodium ion homeostasis.
    Type: Application
    Filed: October 15, 2013
    Publication date: February 13, 2014
    Applicant: Relypsa, Inc.
    Inventors: Michael J. Cope, Paul Mansky, Futian Liu, Han-Ting Chang, Dominique Charmot, Eric Connor, Kalpesh Biyani, Mingjun Liu, Tony Kwok-Kong Mong, Yan Chen
  • Publication number: 20140030362
    Abstract: The invention provides a process for producing a composition comprising natural alumino-silicate minerals having improved reactivity for use in methods of animal husbandry, veterinary and pharmaceutical treatment, comprising irradiating natural alumino-silicate minerals in a liquid suspension with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz, the liquid suspension having a boiling temperature of below 120° C. The invention also provides a method of treating digestive ailments in animals comprising administering to an animal in need of same an effective amount of a composition comprising at least one natural alumina-silicate mineral which has been irradiated with transverse electromagnetic wave radiation in the range of 1,800 MHz to 3,000 MHz.
    Type: Application
    Filed: December 15, 2011
    Publication date: January 30, 2014
    Applicant: TUFFROCK TECHNOLOGY PTY LIMITED
    Inventor: Roger Albert Alfred Smith
  • Patent number: 8637091
    Abstract: The present invention provides a composition comprising functional mineral that is substantially free of crystalline silica. The agricultural particle film composition may be applied to horticultural plants and animals.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: January 28, 2014
    Assignee: Tessenderlokerley Inc
    Inventors: Richard C. Pluta, John T. Mosko
  • Publication number: 20130344131
    Abstract: Hemostatic devices for promoting blood clotting can include a substrate (e.g., gauze, textile, sponge, sponge matrix, one or more fibers, etc.), a hemostatic material disposed thereon such as kaolin clay, and a binder material such as crosslinked calcium alginate with a high guluronate monomer molar percentage disposed on the substrate to substantially retain the hemostatic material material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood to accelerate clotting. Moreover, when exposed to blood, the binder has low solubility and retains a majority of the clay material on the gauze. A bandage that can be applied to a bleeding wound to promote blood clotting includes a flexible substrate and a gauze substrate mounted thereon.
    Type: Application
    Filed: June 19, 2013
    Publication date: December 26, 2013
    Inventors: Denny Lo, Dina Dubey
  • Patent number: 8603543
    Abstract: The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: December 10, 2013
    Assignee: The Regents of the University of California
    Inventors: Galen Stucky, Sarah Baker, April Sawvel
  • Publication number: 20130309325
    Abstract: The present invention provides compositions comprising silicon and at least one other joint health ingredient such as glucosamine, chondroitin, hyaluronic acid, collage, etc. as well as methods for making and using the same.
    Type: Application
    Filed: May 21, 2012
    Publication date: November 21, 2013
    Applicant: VITAL ANIMAL HEALTH, LLC
    Inventor: Brian A. Crook
  • Publication number: 20130299121
    Abstract: The present disclosure relates to the preparation of a polymer composite material for building air conditioning or dehumidification having superior water-adsorbing ability, durability and antibacterial properties by electro spinning. Specifically, the disclosed method for preparing a polymer composite material for building air conditioning or dehumidification includes: (S1) adding a crosslinking agent or a crosslinking agent and a porous filler for conferring durability and antibacterial properties into a hydrophilic polymer solution antibacterial properties to prepare a polymer composite material solution; (S2) electrospinning the polymer composite material solution to prepare a nanofiber sheet; and (S3) crosslinking the nanofiber sheet by heat-treatment.
    Type: Application
    Filed: December 15, 2010
    Publication date: November 14, 2013
    Inventors: Young-soo Ahn, Jeong-gu Yeo, Kuck-tack Chue, Churl-hee Cho, Chang-kook Hong, Sang-youn Oh, Se-hee Kim, Hyeong-seon Oh, Jae-sik Ryu, Seung-hyun Shin
  • Patent number: 8568791
    Abstract: The present invention herein provides antibacterial zeolite particles whose ion-exchangeable ions have completely or partially been replaced with silver ions and zinc ions, wherein the ratio (A/B) of the silver ion concentration (A) to the zinc ion concentration (B) in the antibacterial zeolite particles increases in the direction along the depth of each zeolite particle. The antibacterial zeolite particles show excellent discoloration-resistant characteristics, while maintaining their excellent antibacterial activities. Accordingly, the antibacterial zeolite particles can suitably be applied to all sorts of products that are required to have antibacterial properties.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: October 29, 2013
    Assignee: Sinanen Zeomic Co., Ltd.
    Inventors: Yasuo Kurihara, Kumiko Miyake, Masashi Uchida
  • Patent number: 8551533
    Abstract: An adjuvant composition is provided which comprises: (a) at least one water-soluble electrolyte; (b) at least one electrolyte-tolerant surfactant; (c) antifoam component which is at least one mixture selected from the group consisting of (1) at least one branched silicone resin (i), at least one silicone fluid (ii), at least one particulate metal oxide (iii) and, optionally, at least one catalyst (iv) for catalyzing the condensation of siloxy groups, (2) the equilibration reaction product of mixture (1), and (3) mixture (1) in which at least a portion of particulate metal oxide (iii) is pre-hydrophobized; (d) optionally, at least one additional bioinert material; and, (e) water.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: October 8, 2013
    Assignee: Momentive Performance Materials Inc.
    Inventors: William L Brown, Kalman Koczo, George A Policello
  • Publication number: 20130243887
    Abstract: The present invention relates to the preparation of zeolites obtained with a method comprising a stage of heating to temperature preferably of over 400° C. and at least one stage of micronisation. Such zeolites are to be used in the pharmaceutical sector, in particular to combat the action of ROS at a mitochondrial level with a neuroprotective effect.
    Type: Application
    Filed: August 3, 2011
    Publication date: September 19, 2013
    Applicants: ECOBASE GMBH
    Inventors: Maurizio Memo, Stefano Manna
  • Patent number: 8501717
    Abstract: The present invention relates to methods useful for treating and/or preventing mucositis using an active vitamin D compound.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: August 6, 2013
    Assignee: Merck, Sharp & Dohme Corp.
    Inventor: Chen Zong
  • Publication number: 20130189371
    Abstract: The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices. The intrinsic bioactivity of the hydrogel matrix makes it useful as a gel or paste in multiple applications, including as a cell attachment scaffold that promotes wound healing around an implanted device, as gels and pastes for induction of localized vasculogenesis, wound healing, tissue repair, and regeneration, as a wound adhesive, and for tissue bulking.
    Type: Application
    Filed: March 11, 2013
    Publication date: July 25, 2013
    Applicant: PIONEER SURGICAL ORTHOBIOLOGICS, INC.
    Inventor: PIONEER SURGICAL ORTHOBIOLOGICS, INC.
  • Publication number: 20130101642
    Abstract: The present disclosure relates generally to the field of oral mucositis. More particularly, methods and compositions for treating, ameliorating and/or preventing oral mucositis are provided. Methods and compositions for treating, ameliorating and/or preventing oral mucositis are also provided.
    Type: Application
    Filed: October 19, 2012
    Publication date: April 25, 2013
    Applicant: Texas Enterosorbents Inc.
    Inventor: Texas Enterosorbents Inc.
  • Patent number: 8409629
    Abstract: A hemostatic agent composition that includes a clay hemostatic agent which is inert and non-reactive relative to blood clotting proteins and platelets, yet is capable of accelerating the formation of a stable clot when applied to an actively bleeding wound.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: April 2, 2013
    Inventors: Jack Mentkow, Lisa Mentkow
  • Publication number: 20130059016
    Abstract: The present invention relates to liquid or semi-solid pharmaceutical compositions, more specifically to aqueous pharmaceutical suspension or semi-solid paste containing natural mineral clays as active ingredients. These compositions are particularly useful for the treatment of acute and chronic diarrhea.
    Type: Application
    Filed: April 29, 2011
    Publication date: March 7, 2013
    Applicant: Ipsen Pharma S.A.S
    Inventors: Béatrice Hacher, Didier Kubiak, Jeremiah Harnett, Nathalie Mondoly
  • Publication number: 20130058880
    Abstract: Compositions, kits and methods of preparing a biocompatible film for cosmetic or medical uses are disclosed. The compositions or kits contain polyvinyl acetal (PVA), siloxane and a solvent. The siloxane can have a hydrophilic group. Once the solvent content is reduced, for instance, by evaporation, the mixture of PVA and siloxane is solidified, forming a film. The compositions and kits, optionally, further include one or more of an antimicrobial agent, a pigment, an anti-inflammatory agent, an anesthetic agent or a hemostatic agent. Such a film can be used, for example, in the form of an antimicrobial sealant, a liquid bandage, body paints, scar camouflage, water-proof sun block, makeup sealer, or antimicrobial wipe or spray.
    Type: Application
    Filed: May 9, 2011
    Publication date: March 7, 2013
    Inventor: Shaosheng Dong
  • Patent number: 8388984
    Abstract: Compositions which deliver adsorbents, alone or in combination with active drug “degrading molecules,” in a site-specific manner to the intestine, and which eliminate or at least lower the concentration of residual unwanted material within the intestine, and methods of treatment using the compositions, are disclosed. The compositions are ideally designed to specifically release the adsorbents in a programmed manner at a specific site of the intestinal tract. Programmed delivery prevents adsorbents from interfering with the normal absorption process of a given molecule after oral absorption, until it reaches the lower part of the small intestine. The compositions can be used to adsorb, and therefore remove, any residual drug, metabolite thereof, or bacterial toxin after oral or parenteral administration which would otherwise cause adverse effects in the lower intestine and/or colon.
    Type: Grant
    Filed: September 14, 2011
    Date of Patent: March 5, 2013
    Assignees: Da Volterra, Centre National de la Recherche Scientifique, Assistance Publique—Hopitaux de Paris, Universite Paris Diderot—Paris 7, Universite Paris-SUD 11
    Inventors: Helene-Celine Huguet, Antoine Andremont, Nicolas Tsapis, Elias Fattal
  • Publication number: 20130039999
    Abstract: The invention relates to the use of a clay for the preparation of a medicament for treating coeliac disease. Preferably, the clay used is of smectite type.
    Type: Application
    Filed: April 13, 2012
    Publication date: February 14, 2013
    Applicant: IPSEN PHARMA S.A.S.
    Inventor: Hélène MATHIEX-FORTUNET
  • Publication number: 20130004585
    Abstract: Methods of fabricating implantable medical devices, preferably with PEEK, having antimicrobial properties, are disclosed. The antimicrobial effect is produced by incorporating ceramic particles containing antimicrobial metal cations into molten PEEK resin, which is subsequently allowed to cool and set in its final shape achieved by injection molding, cutting and machining or other techniques.
    Type: Application
    Filed: December 10, 2010
    Publication date: January 3, 2013
    Applicant: DIFUSION TECHNOLOGIES, INC.
    Inventors: Joseph J. Crudden, Jami Hafiz, James E. Deaton, John R. Pepper, Derrick Johns
  • Patent number: 8343467
    Abstract: Glycopyrronium bromide, derivatives and/or isomers thereof in combination with one or more active substances selected from a list of substances as recited in the claims and/or in the form of a W/Si emulsion, an O/W gel, a soap gel stick, and/or a surfactant-containing cleansing formula, and corresponding cosmetic preparations, in particular deodorant/antiperspirant preparations.
    Type: Grant
    Filed: December 27, 2005
    Date of Patent: January 1, 2013
    Assignee: Beiersdorf AG
    Inventors: Michael Woehrmann, Lara Terstegen, Stefan Biel, Thomas Raschke, Svenja-Kathrin Cerv, Werner Zilz, Sven Untiedt, Thomas Nuebel, Uwe Schoenrock, Heiner Max, Helga Biergiesser, Yvonne Eckhard, Heike Miertsch, Heike Foelster, Cornelia Meier-Zimmerer, Bernd Traupe, Inge Kruse
  • Publication number: 20120328672
    Abstract: A low heavy metal (i.e. cadmium, mercury) containing calcium aluminum silicate product produced by the method of Air Classification. The method comprises using an air classification system for separating a cadmium containing calcium aluminum silicate feed stock into at least a first fraction and a second fraction. The first separation fraction contains material having an average particle size over 100 um, and the second fraction contains material having an average particle size under 100 um.
    Type: Application
    Filed: June 15, 2012
    Publication date: December 27, 2012
    Inventors: Craig Conrad, Donald Jones
  • Publication number: 20120321691
    Abstract: A device for promoting the clotting of blood comprises a clay material in particle form and a receptacle for containing the clay material. At least a portion of the receptacle is defined by a mesh. Another device comprises a gauze substrate and a clay material disposed on the gauze substrate. Another device is a bandage comprising a substrate, a mesh mounted on the substrate, and particles of a clay material retained in the mesh. A hemostatic sponge comprises a substrate, a hemostatic material disposed on a first surface of the substrate, and a release agent disposed on a second surface of the substrate. The release agent is disposed on the wound-contacting surface of the substrate. When treating a bleeding wound, application of the hemostatic sponge causes at least a portion of the hemostatic material to come into contact with blood through the release agent and through the substrate.
    Type: Application
    Filed: August 23, 2012
    Publication date: December 20, 2012
    Applicant: Z-medica Corporation
    Inventors: Raymond J. Huey, Denny Lo, Daniel J. Burns, Giacomo Basadonna, Francis X. Hursey
  • Publication number: 20120308541
    Abstract: Provided are pharmaceutical compositions for the treatment or prophylaxis of the gastrointestinal tract. One of the pharmaceutical composition includes co-particles of an adsorbent, and one or more carbohydrates. This pharmaceutical composition may be used, for example, in the treatment or prophylaxis of diarrhea, for adsorbing digestive tract microorganisms, for enhancing weight gain, or for enhancing milk production in a mammal. Another pharmaceutical composition can include one or more enzymes and a pH buffer system, wherein the pH buffer system causes an alkalinization of at least a portion of a gastrointestinal tract. This pharmaceutical composition may be used, for example, for increasing milk production in a mammal.
    Type: Application
    Filed: February 9, 2011
    Publication date: December 6, 2012
    Inventor: Eliezer Smoler
  • Publication number: 20120269900
    Abstract: The present invention relates to compositions and methods for deterring and repelling all types of organisms capable of sensing electric or magnetic fields, including insects and arachnids. The compositions contain electrically or magnetically imprintable substances comprising an electric or magnetic charge or imprint, wherein the imprint contains the signature of at least one target organism; and an acceptable carrier.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 25, 2012
    Inventor: D. Tobin Watkinson
  • Publication number: 20120219612
    Abstract: Compositions comprising clay minerals and methods for their use in promoting hemostasis are provided. The compositions comprise clay minerals such as bentonite, and facilitate blood clotting when applied to a hemorrhaging wound. Electrospun or electrosprayed materials (e.g. bandages, micron beads, etc.) which include clay minerals, and methods for the treatment of acute hemorrhage, are also provided.
    Type: Application
    Filed: May 10, 2012
    Publication date: August 30, 2012
    Inventors: Robert F. Diegelmann, Kevin R. Ward, Marcus E. Carr, Gary Lee Bowlin
  • Patent number: 8252344
    Abstract: A composition for promoting the formation of clots in blood comprises a zeolite and a binder. The zeolite is adjusted to have a specific moisture content. Processes by which the moisture content is adjusted include drying, re-hydrating, and combinations of drying and re-hydrating. A method of forming the composition comprises the steps of providing a zeolite and adjusting the moisture content such that upon application of the composition to a wound, a heat of hydration is reduced and heat transferred to the wound is reduced. A method of clotting blood flowing from a wound comprises the steps of applying the zeolite to the wound and maintaining the zeolite in contact with the wound for a predetermined amount of time, the zeolite having an adjusted moisture content and being capable of producing a controllable exothermic effect on the wound.
    Type: Grant
    Filed: September 13, 2004
    Date of Patent: August 28, 2012
    Assignee: Z-Medica Corporation
    Inventor: Francis X. Hursey
  • Patent number: 8252342
    Abstract: A method for producing a complex of metallic nanoparticles and inorganic clay and an organic promoter, wherein the organic promoter is ethanolamine, for example, monoethanolamine (MEA), diethanolamine (DEA) or triethanolamine (TEA). The metallic nanoparticles produced by this method can be stably and uniformly dispersed without adding other reducing agent or dispersant.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: August 28, 2012
    Assignee: National Taiwan University
    Inventors: Jiang-Jen Lin, Yueh-Hsien Wu
  • Publication number: 20120201905
    Abstract: The present invention provides a W/O emulsion cosmetic excellent in the feeling in use and stability. The W/O emulsion cosmetic of the present invention comprises the following components (A) to (F): (A) 0.1 to 5 mass % of polyoxyalkylene/alkyl-comodified silicone; (B) polyoxyalkylene-modified silicone, being 0.2 to 3 times in mass with respect to the component (A); (C) 5 to 50 mass % of powder; (D) 10 to 50 mass % of a volatile oil; (E) 1 to 20 mass % of ethanol; and (F) water. In addition, the dispersion stability of powder and viscosity stability of the composition can be improved, by further blending sodium glutamate or by further blending an organically modified clay mineral and diglyceryl diisostearate therein. Furthermore, if glycerin and a specific nonvolatile oil are blended therein, the moisturizing property can be improved.
    Type: Application
    Filed: June 3, 2010
    Publication date: August 9, 2012
    Applicant: SHISEIDO COMPANY, LTD.
    Inventors: Yoriko Mune, Hideo Hata, Yukiko Sato, Katsuyuki Hasegawa
  • Publication number: 20120171255
    Abstract: The invention relates to the production of a clay-impregnated substrate (10), including a step in which a pasty material (3), containing clay mixed with a liquid, is sprayed onto a substrate (1) having an aerated structure.
    Type: Application
    Filed: July 7, 2010
    Publication date: July 5, 2012
    Inventors: Valérie Fontas, Claude Martin